Refractory Pancreatic Neuroendocrine Carcinoma
2 clinical trials · Condition
◉ Watch Refractory Pancreatic Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin (NCT03736720) | Roswell Park Cancer Institute | 2019-06-17 |
| Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery (NCT02893930) | National Cancer Institute (NCI) | 2017-04-28 |
Track Refractory Pancreatic Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.